The role of the carboxyl-terminal fragments of amyloid precursor protein in Alzheimer's disease

Debomoy Lahiri, G. J. Kotwal, Martin Farlow, A. Sima, W. Kupsky, F. H. Sarkar, K. Sambamurti

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Two major pathological hallmarks of Alzheimer's disease (AD) are the senile plaques that are primarily composed of amyloid β-peptide (Aβ) and neurofibrillary tangles consisting of tau aggregates. Aβ is generated proteolytically from a family of Aβ-containing precursor proteins (APP; 695-770 amino acid) by secretase enzymes to different specific carboxyl-terminal fragments (CTFs). Herein we examined APP and its products in autopsied brain sections from 10 AD and 10 non-AD control subjects immunochemically using an antibody that was raised against APP751-770 residue (O443). The O443 antibody was initially characterized by Western blot analysis and immunoprecipitation. In this study, we used this antibody for immunohistochemical analysis to determine the distribution of APP and its CTF species. In 10 brain regions showing different levels of plaques and tangles, antibody O443 stained the perinuclear region of the nucleus, plaques, and neurites. Tangle-bearing neurons also appeared to stain with the antibody, suggesting that these dysfunctional neurons continue to synthesize APP/CTF. Alternatively, the normally short-lived APP/CTF can be stabilized and persist in these neurons. Taken together, these results suggest that, in addition to the widely believed role of Aβ, CTFs may play a key role in the pathogenesis of AD. Studying their localization and biogenesis may reveal the biological activities of CTFs of APP. The present study may pave the way for possible antiamyloidogenic therapy in the treatment of AD.

Original languageEnglish
Pages (from-to)334-339
Number of pages6
JournalAnnals of the New York Academy of Sciences
Volume973
StatePublished - 2002

Fingerprint

Amyloid beta-Protein Precursor
Alzheimer Disease
Antibodies
Neurons
Brain
Bearings (structural)
Disease control
Amyloid Precursor Protein Secretases
Neurofibrillary Tangles
Protein Precursors
Amyloid Plaques
Neurites
Bioactivity
Immunoprecipitation
Amyloid
Coloring Agents
Western Blotting
Protein
Precursor
Alzheimer's Disease

Keywords

  • Alzheimer's disease
  • Amyloid β-peptide
  • Amyloid precursor protein
  • Carboxyl-truncated fragments
  • Neurofibrillary tangles

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

The role of the carboxyl-terminal fragments of amyloid precursor protein in Alzheimer's disease. / Lahiri, Debomoy; Kotwal, G. J.; Farlow, Martin; Sima, A.; Kupsky, W.; Sarkar, F. H.; Sambamurti, K.

In: Annals of the New York Academy of Sciences, Vol. 973, 2002, p. 334-339.

Research output: Contribution to journalArticle

Lahiri, Debomoy ; Kotwal, G. J. ; Farlow, Martin ; Sima, A. ; Kupsky, W. ; Sarkar, F. H. ; Sambamurti, K. / The role of the carboxyl-terminal fragments of amyloid precursor protein in Alzheimer's disease. In: Annals of the New York Academy of Sciences. 2002 ; Vol. 973. pp. 334-339.
@article{d27b8650a1ff49f28600ba9f86296990,
title = "The role of the carboxyl-terminal fragments of amyloid precursor protein in Alzheimer's disease",
abstract = "Two major pathological hallmarks of Alzheimer's disease (AD) are the senile plaques that are primarily composed of amyloid β-peptide (Aβ) and neurofibrillary tangles consisting of tau aggregates. Aβ is generated proteolytically from a family of Aβ-containing precursor proteins (APP; 695-770 amino acid) by secretase enzymes to different specific carboxyl-terminal fragments (CTFs). Herein we examined APP and its products in autopsied brain sections from 10 AD and 10 non-AD control subjects immunochemically using an antibody that was raised against APP751-770 residue (O443). The O443 antibody was initially characterized by Western blot analysis and immunoprecipitation. In this study, we used this antibody for immunohistochemical analysis to determine the distribution of APP and its CTF species. In 10 brain regions showing different levels of plaques and tangles, antibody O443 stained the perinuclear region of the nucleus, plaques, and neurites. Tangle-bearing neurons also appeared to stain with the antibody, suggesting that these dysfunctional neurons continue to synthesize APP/CTF. Alternatively, the normally short-lived APP/CTF can be stabilized and persist in these neurons. Taken together, these results suggest that, in addition to the widely believed role of Aβ, CTFs may play a key role in the pathogenesis of AD. Studying their localization and biogenesis may reveal the biological activities of CTFs of APP. The present study may pave the way for possible antiamyloidogenic therapy in the treatment of AD.",
keywords = "Alzheimer's disease, Amyloid β-peptide, Amyloid precursor protein, Carboxyl-truncated fragments, Neurofibrillary tangles",
author = "Debomoy Lahiri and Kotwal, {G. J.} and Martin Farlow and A. Sima and W. Kupsky and Sarkar, {F. H.} and K. Sambamurti",
year = "2002",
language = "English",
volume = "973",
pages = "334--339",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The role of the carboxyl-terminal fragments of amyloid precursor protein in Alzheimer's disease

AU - Lahiri, Debomoy

AU - Kotwal, G. J.

AU - Farlow, Martin

AU - Sima, A.

AU - Kupsky, W.

AU - Sarkar, F. H.

AU - Sambamurti, K.

PY - 2002

Y1 - 2002

N2 - Two major pathological hallmarks of Alzheimer's disease (AD) are the senile plaques that are primarily composed of amyloid β-peptide (Aβ) and neurofibrillary tangles consisting of tau aggregates. Aβ is generated proteolytically from a family of Aβ-containing precursor proteins (APP; 695-770 amino acid) by secretase enzymes to different specific carboxyl-terminal fragments (CTFs). Herein we examined APP and its products in autopsied brain sections from 10 AD and 10 non-AD control subjects immunochemically using an antibody that was raised against APP751-770 residue (O443). The O443 antibody was initially characterized by Western blot analysis and immunoprecipitation. In this study, we used this antibody for immunohistochemical analysis to determine the distribution of APP and its CTF species. In 10 brain regions showing different levels of plaques and tangles, antibody O443 stained the perinuclear region of the nucleus, plaques, and neurites. Tangle-bearing neurons also appeared to stain with the antibody, suggesting that these dysfunctional neurons continue to synthesize APP/CTF. Alternatively, the normally short-lived APP/CTF can be stabilized and persist in these neurons. Taken together, these results suggest that, in addition to the widely believed role of Aβ, CTFs may play a key role in the pathogenesis of AD. Studying their localization and biogenesis may reveal the biological activities of CTFs of APP. The present study may pave the way for possible antiamyloidogenic therapy in the treatment of AD.

AB - Two major pathological hallmarks of Alzheimer's disease (AD) are the senile plaques that are primarily composed of amyloid β-peptide (Aβ) and neurofibrillary tangles consisting of tau aggregates. Aβ is generated proteolytically from a family of Aβ-containing precursor proteins (APP; 695-770 amino acid) by secretase enzymes to different specific carboxyl-terminal fragments (CTFs). Herein we examined APP and its products in autopsied brain sections from 10 AD and 10 non-AD control subjects immunochemically using an antibody that was raised against APP751-770 residue (O443). The O443 antibody was initially characterized by Western blot analysis and immunoprecipitation. In this study, we used this antibody for immunohistochemical analysis to determine the distribution of APP and its CTF species. In 10 brain regions showing different levels of plaques and tangles, antibody O443 stained the perinuclear region of the nucleus, plaques, and neurites. Tangle-bearing neurons also appeared to stain with the antibody, suggesting that these dysfunctional neurons continue to synthesize APP/CTF. Alternatively, the normally short-lived APP/CTF can be stabilized and persist in these neurons. Taken together, these results suggest that, in addition to the widely believed role of Aβ, CTFs may play a key role in the pathogenesis of AD. Studying their localization and biogenesis may reveal the biological activities of CTFs of APP. The present study may pave the way for possible antiamyloidogenic therapy in the treatment of AD.

KW - Alzheimer's disease

KW - Amyloid β-peptide

KW - Amyloid precursor protein

KW - Carboxyl-truncated fragments

KW - Neurofibrillary tangles

UR - http://www.scopus.com/inward/record.url?scp=0036964877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036964877&partnerID=8YFLogxK

M3 - Article

VL - 973

SP - 334

EP - 339

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -